8-K - AGARWAL TRANSITION AGREEMENT

Company

Sana Biotechnology, Inc.

Filed

April 28, 2023

Period of Report

April 28, 2023

Accession Number

0001564590-23-006600

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →